Presentation is loading. Please wait.

Presentation is loading. Please wait.

Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence?  Chase R. Brown, MD, Fabliha.

Published byAntonia Antonucci Modified over 5 years ago

Similar presentations

Presentation on theme: "Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence?  Chase R. Brown, MD, Fabliha."— Presentation transcript:

1 Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence?  Chase R. Brown, MD, Fabliha Khurshan, BA, Zehang Chen, BA, BSN, Peter W. Groeneveld, MD, Fenton McCarthy, MD, MS, Michael Acker, MD, J. Eduardo Rame, MD, Nimesh Desai, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 157, Issue 6, Pages e4 (June 2019) DOI: /j.jtcvs Copyright © Terms and Conditions

2 Figure 1 Flow chart of patient inclusion and exclusion criteria. BTT, Bridged to transplant; LVAD, left ventricular assist device. The Journal of Thoracic and Cardiovascular Surgery  , e4DOI: ( /j.jtcvs ) Copyright © Terms and Conditions

3 Figure 2 Survival after heart transplantation based on bridge to transplant (BTT) duration with a left ventricular assist device. The 95% confidence intervals for survival can be found in Table E1. The Journal of Thoracic and Cardiovascular Surgery  , e4DOI: ( /j.jtcvs ) Copyright © Terms and Conditions

4 Figure 3 Hazard ratio for mortality after heart transplantation based on bridge to transplant duration with a left ventricular assist device (LVAD). The Journal of Thoracic and Cardiovascular Surgery  , e4DOI: ( /j.jtcvs ) Copyright © Terms and Conditions

5 Figure E1 A histogram of patients bridged to transplant with a left ventricular assist device. The Journal of Thoracic and Cardiovascular Surgery  , e4DOI: ( /j.jtcvs ) Copyright © Terms and Conditions

6 Risk of death after heart transplant based on bridge to transplant duration with an LVAD.
The Journal of Thoracic and Cardiovascular Surgery  , e4DOI: ( /j.jtcvs ) Copyright © Terms and Conditions

7 The Journal of Thoracic and Cardiovascular Surgery 2019 157, 2315-2324
The Journal of Thoracic and Cardiovascular Surgery  , e4DOI: ( /j.jtcvs ) Copyright © Terms and Conditions

Download ppt "Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence?  Chase R. Brown, MD, Fabliha."

Similar presentations

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W
Manuel J. Antunes, MD, PhD, DSc 

Manuel J. Antunes, MD, PhD, DSc 
Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
A hybrid configuration of a left ventricular assist device and venovenous extracorporeal membrane oxygenation  Louis Samuels, MD, Eric Gnall, DO, Elena.

A hybrid configuration of a left ventricular assist device and venovenous extracorporeal membrane oxygenation  Louis Samuels, MD, Eric Gnall, DO, Elena.
Long-term mechanical circulatory support: A new disease state?

Long-term mechanical circulatory support: A new disease state?
Moderate mitral regurgitation in aortic root replacement surgery: Comparing mitral repair with no mitral repair  Fenton H. McCarthy, MD, Nimesh D. Desai,

Moderate mitral regurgitation in aortic root replacement surgery: Comparing mitral repair with no mitral repair  Fenton H. McCarthy, MD, Nimesh D. Desai,
The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy  John W.C.

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy  John W.C.
Shinichi Fukuhara, MD, Koji Takeda, MD, PhD, Paul A

Shinichi Fukuhara, MD, Koji Takeda, MD, PhD, Paul A
Stenting of an outflow graft obstruction after implantation of a continuous-flow, axial-flow left ventricular assist device  Duc Thinh Pham, MD, Navin.

Stenting of an outflow graft obstruction after implantation of a continuous-flow, axial-flow left ventricular assist device  Duc Thinh Pham, MD, Navin.
Association of device surface and biomaterials with immunologic sensitization after mechanical support  Isaac George, MD, Patrick Colley, BS, Mark J.

Association of device surface and biomaterials with immunologic sensitization after mechanical support  Isaac George, MD, Patrick Colley, BS, Mark J.
Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 
New anticoagulant coatings and hemostasis assessment tools to avoid complications with pediatric left ventricular assist devices  Daniel C. Leslie, PhD,

New anticoagulant coatings and hemostasis assessment tools to avoid complications with pediatric left ventricular assist devices  Daniel C. Leslie, PhD,
Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices  Ranjit John, MD, Kenneth Liao,

Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices  Ranjit John, MD, Kenneth Liao,
Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 

Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic.

Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic.
Form ever follows function

Form ever follows function
William M. DeCampli, MD, PhD 

William M. DeCampli, MD, PhD 
Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure  Allison P. Levin, BA, MSc,

Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure  Allison P. Levin, BA, MSc,

Similar presentations

Ads by Google